Congresswoman McClain Introduces Safe RESEARCH Act to Prohibit the Sale of Fetal Tissue
WASHINGTON, D.C. – This week, Congresswoman Lisa McClain (R-MI) introduced legislation that would prohibit the sale of fetal tissue following an abortion.
The Safe Responsible, Ethical Scientific Endeavors Assuring Research for Compassionate Healthcare (RESEARCH) Act would amend Section 498A of the Public Health Act to include fetal tissue may be used for research purposes, but only if it is obtained as the result of a stillbirth or ectopic pregnancy, not from an abortion.
“We must protect innocent unborn babies in every way we can,” said Rep. McClain. “The Safe RESEARCH Act not only protects life, it also ensures scientists can continue important research so long as they’re not using fetal tissue from abortions.”
Harvesting and selling fetal tissue is a horrific and gruesome process. Due to advancements in medical technology, such as adult stem cell science, fetal tissue is an unnecessary option for medical researchers.